American Journal of Respiratory Cell and Molecular Biology. Vol. 27, pp. 406-412, 2002
© 2002 American Thoracic Society DOI: 10.1165/rcmb.4782
HLA-DQB1*0201
A Marker for Good Prognosis in British and Dutch Patients with Sarcoidosis
Hiroe Sato*,
Jan C. Grutters*,
Panagiotis Pantelidis,
A. Neil Mizzon,
Tariq Ahmad,
Arend-Jan van Houte,
Jan-Willem J. Lammers,
Jules M.M. van den Bosch,
Kenneth I. Welsh and
Roland M. du Bois
Clinical Genomics Group, Department of Occupational and Environmental Medicine, Imperial College of Science, Technology and Medicine, National Heart and Lung Institute, London, United Kingdom; Heart Lung Center Utrecht, Department of Pulmonology, Sint Antonius Hospital, Nieuwegein, The Netherlands; Department of Gastroenterology, Radcliffe Hospital, Oxford, United Kingdom; Department of Medical Microbiology & Immunology, Sint Antonius Hospital, Nieuwegein; and Heart Lung Center Utrecht, Department of Pulmonology, University Medical Center, Utrecht, The Netherlands
Address correspondence to: Professor R.M. du Bois, M.D., Clinical Genomics Group, National Heart and Lung Institute, 1B Manresa Road, London SW3 6LR, UK. Email: r.dubois{at}rbh.nthames.nhs.uk
Human leukocyte antigen (HLA)-DQB1 is one of the intriguing candidate genes in sarcoidosis. We performed high resolution molecular HLA-DQB1 typing on two groups of white patients (British [UK] and Dutch [NL]) in order to investigate the relationship between 19 DQB1 alleles and disease severity and progression. A total of 803 individuals were studied (133 UK and 102 NL patients, and 354 UK and 214 NL control subjects). Disease severity data included extrapulmonary disease, chest X-ray stage, lung diffusing capacity for carbon monoxide, and FVC. Progression was evaluated on follow-up chest radiographs (2 and 4 yr). The results showed DQB1*0201 to be strongly protective against severe sarcoidosis in both populations; in other words, it localized to Stage I at all time points (P < 0.0001, Pcorrected (Pc) = 0.002), whereas another DQB1 allele, *0602, tended to have opposite effects. Further, a clear association was found between the *0201 allele and Löfgren's syndrome (P < 0.0001, Pc = 0.001). More importantly, carriage of this allele reduced the risk of disease progression. In contrast, the other common split of DQB1*02, *0202, did not affect disease severity but was mildly protective against sarcoidosis in the UK population (P = 0.02, pc not significant). In conclusion, this study shows that DQB1*0201 is a strong marker for mild sarcoidosis. Additional mapping across the DQB1*0201-DRB1*0301 haplotype, including specific alleles at genes such as DRB3, tumor necrosis factor, lymphotoxin- , I-kappa-B-like protein, and B-associated transcript 1, is necessary for a final localization of the protective effect on this haplotype.
Abbreviations: bilateral hilar lymphadenopathy, BHL degrees of freedom, df diffusing capacity of the lung for carbon monoxide, DLCO erythema nodosum, EN human leukocyte antigen, HLA major histocompatibility complex, MHC P values corrected for the number of DQ alleles tested, Pc polymerase chain reaction, PCR sequence-specific primers, SSPs
This article has been cited by other articles:

|
 |

|
 |
 
A. Prasse, C. Katic, M. Germann, A. Buchwald, G. Zissel, and J. Muller-Quernheim
Phenotyping Sarcoidosis from a Pulmonary Perspective
Am. J. Respir. Crit. Care Med.,
February 1, 2008;
177(3):
330 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Iannuzzi, B. A. Rybicki, and A. S. Teirstein
Sarcoidosis
N. Engl. J. Med.,
November 22, 2007;
357(21):
2153 - 2165.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Jonth, L. Silveira, T. E. Fingerlin, H. Sato, J. C. Luby, K. I. Welsh, C. S. Rose, L. S. Newman, R. M. du Bois, L. A. Maier, et al.
TGF-beta1 Variants in Chronic Beryllium Disease and Sarcoidosis
J. Immunol.,
September 15, 2007;
179(6):
4255 - 4262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Spagnolo, H. Sato, S. E. Marshall, K. M. Antoniou, T. Ahmad, A. U. Wells, M. A. Ahad, S. Lightman, R. M. du Bois, and K. I. Welsh
Association between Heat Shock Protein 70/Hom Genetic Polymorphisms and Uveitis in Patients with Sarcoidosis
Invest. Ophthalmol. Vis. Sci.,
July 1, 2007;
48(7):
3019 - 3025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Iannuzzi and R. P. Baughman
Reverse Phenotyping in Sarcoidosis
Am. J. Respir. Crit. Care Med.,
January 1, 2007;
175(1):
4 - 5.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Iannuzzi and B. A. Rybicki
Genetics of Sarcoidosis: Candidate Genes and Genome Scans
Proceedings of the ATS,
January 1, 2007;
4(1):
108 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kriegova, C. Melle, V. Kolek, B. Hutyrova, F. Mrazek, A. Bleul, R. M. du Bois, F. von Eggeling, and M. Petrek
Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1145 - 1154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Spagnolo, E. A. Renzoni, A. U. Wells, S. J. Copley, S. R. Desai, H. Sato, J. C. Grutters, A. Abdallah, A. Taegtmeyer, R. M. du Bois, et al.
C-C Chemokine Receptor 5 Gene Variants in Relation to Lung Disease in Sarcoidosis
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
721 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Valentonyte, J. Hampe, P. J. P. Croucher, J. Muller-Quernheim, E. Schwinger, S. Schreiber, and M. Schurmann
Study of C-C Chemokine Receptor 2 Alleles in Sarcoidosis, with Emphasis on Family-based Analysis
Am. J. Respir. Crit. Care Med.,
May 15, 2005;
171(10):
1136 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Lagan, P. Pantelidis, E. A. Renzoni, C. Fonseca, P. Beirne, A. B. Taegtmeyer, C. P. Denton, C. M. Black, A. U. Wells, R. M. du Bois, et al.
Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma
Rheumatology,
February 1, 2005;
44(2):
197 - 201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Taylor and P. Cullinan
Sarcoidosis: In Search of the Cause
Am. J. Respir. Crit. Care Med.,
December 15, 2004;
170(12):
1268 - 1269.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Rybicki and M. C. Iannuzzi
Sarcoidosis and Human Leukocyte Antigen Class I and II Genes: It Takes Two to Tango?
Am. J. Respir. Crit. Care Med.,
March 15, 2004;
169(6):
665 - 666.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Grunewald, A. Eklund, and O. Olerup
Human Leukocyte Antigen Class I Alleles and the Disease Course in Sarcoidosis Patients
Am. J. Respir. Crit. Care Med.,
March 15, 2004;
169(6):
696 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohchi, N. Shijubo, I. Kawabata, S. Ichimiya, S.-i. Inomata, A. Yamaguchi, Y. Umemori, Y. Itoh, S. Abe, Y. Hiraga, et al.
Polymorphism of Clara Cell 10-kD Protein Gene of Sarcoidosis
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
180 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. O'Regan and J. S. Berman
The Gene for Acute Sarcoidosis?
Am. J. Respir. Crit. Care Med.,
November 15, 2003;
168(10):
1142 - 1143.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Spagnolo, E. A. Renzoni, A. U. Wells, H. Sato, J. C. Grutters, P. Sestini, A. Abdallah, E. Gramiccioni, H. J. T. Ruven, R. M. du Bois, et al.
C-C Chemokine Receptor 2 and Sarcoidosis: Association with Lofgren's Syndrome
Am. J. Respir. Crit. Care Med.,
November 15, 2003;
168(10):
1162 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schurmann, R. Valentonyte, J. Hampe, J. Muller-Quernheim, E. Schwinger, and S. Schreiber
CARD15 gene mutations in sarcoidosis
Eur. Respir. J.,
November 1, 2003;
22(5):
748 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al.
Idiopathic Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol.,
September 1, 2003;
29(3):
S1 - 105.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rothkrantz-Kos, M. P. van Dieijen-Visser, P. G.H. Mulder, and M. Drent
Potential Usefulness of Inflammatory Markers to Monitor Respiratory Functional Impairment in Sarcoidosis
Clin. Chem.,
September 1, 2003;
49(9):
1510 - 1517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Baughman and E. E. Lower
The Variability of Sarcoidosis: Can We Predict It?
Chest,
May 1, 2003;
123(5):
1329 - 1332.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Iannuzzi, M. J. Maliarik, L. M. Poisson, and B. A. Rybicki
Sarcoidosis Susceptibility and Resistance HLA-DQB1 Alleles in African Americans
Am. J. Respir. Crit. Care Med.,
May 1, 2003;
167(9):
1225 - 1231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Rybicki, M. J. Maliarik, L. M. Poisson, R. Sheffer, K. M. Chen, M. Major, G. A. Chase, and M. C. Iannuzzi
The Major Histocompatibility Complex Gene Region and Sarcoidosis Susceptibility in African Americans
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
444 - 449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Moller and E. S. Chen
Genetic Basis of Remitting Sarcoidosis: Triumph of the Trimolecular Complex?
Am. J. Respir. Cell Mol. Biol.,
October 1, 2002;
27(4):
391 - 395.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society.
|
|
|